David Bennett to Proteomics
This is a "connection" page, showing publications David Bennett has written about Proteomics.
Connection Strength
3.767
-
Proteomic Profiling of the Substantia Nigra to Identify Determinants of Lewy Body Pathology and Dopaminergic Neuronal Loss. J Proteome Res. 2021 05 07; 20(5):2266-2282.
Score: 0.694
-
A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research. Sci Data. 2018 08 07; 5:180142.
Score: 0.574
-
Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol. 2018 07; 84(1):78-88.
Score: 0.571
-
Optimized Glycopeptide Enrichment Method-It Is All About the Sauce. Anal Chem. 2022 07 26; 94(29):10308-10313.
Score: 0.188
-
Inferring protein expression changes from mRNA in Alzheimer's dementia using deep neural networks. Nat Commun. 2022 02 03; 13(1):655.
Score: 0.183
-
Association of small vessel disease with tau pathology. Acta Neuropathol. 2022 03; 143(3):349-362.
Score: 0.182
-
Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics. Neurobiol Aging. 2021 09; 105:99-114.
Score: 0.173
-
Enhancing Top-Down Proteomics of Brain Tissue with FAIMS. J Proteome Res. 2021 05 07; 20(5):2780-2795.
Score: 0.173
-
Brain proteome-wide association study implicates novel proteins in depression pathogenesis. Nat Neurosci. 2021 06; 24(6):810-817.
Score: 0.173
-
Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain. Nat Neurosci. 2020 06; 23(6):696-700.
Score: 0.162
-
Association of Cortical ?-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. JAMA Neurol. 2019 07 01; 76(7):818-826.
Score: 0.153
-
High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. Clin Chem. 2005 Oct; 51(10):1946-54.
Score: 0.058
-
Proteome-wide Analyses Identified Cortical Proteins Associated With Resilience for Varied Cognitive Abilities. Neurology. 2024 Jan 09; 102(1):e207816.
Score: 0.052
-
Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease. Neurobiol Aging. 2023 06; 126:25-33.
Score: 0.049
-
Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci. 2022 02; 25(2):213-225.
Score: 0.046
-
Brain microRNAs are associated with variation in cognitive trajectory in advanced age. Transl Psychiatry. 2022 02 01; 12(1):47.
Score: 0.046
-
Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease. Alzheimers Dement. 2022 06; 18(6):1260-1278.
Score: 0.045
-
Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. Neuron. 2021 11 03; 109(21):3402-3420.e9.
Score: 0.044
-
Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample. Acta Neuropathol. 2021 05; 141(5):755-770.
Score: 0.043
-
Genetic control of the human brain proteome. Am J Hum Genet. 2021 03 04; 108(3):400-410.
Score: 0.043
-
Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020 05; 26(5):769-780.
Score: 0.040
-
Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons. J Affect Disord. 2019 05 01; 250:313-318.
Score: 0.037
-
Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019 01 24; 10(1):409.
Score: 0.037